Our flagship product, Polybion A Injection , is a premium healthcare solution used primarily for addressing nutritional deficiencies and promoting overall wellness
1 Despite these constraints, the commercial consequence has been significant: Medicare logged $27.5 billion in gross GLP-1 spending across 21.8 million claims in 2024, entirely under FDA-approved indications other than obesity
Furthermore, GLP-1Rs have been shown to be able to stimulate the depolarization-evoked release of other neurotransmitters, such as GABA and glutamate, as well as of serotonin and dopamine, in the cortex and hippocampus (Rebosio et al., 2018)
It does not provide nutrition advice for specific medical conditions or replace a licensed clinician
Still, it may be a helpful add-on for adults with type 2 diabetes when used under a health care provider's supervision